Search Results

Superpotency: Why More Isn’t Better When It Comes to Prescription and OTC Drugs Ferring Pharmaceuticals US recently announced that it is recalling four types of nasal sprays containing desmopressin due to superpotency: DDVAP Nasal Spray 10 mcg/0.1mL, which is used as an anti-diuretic replacement therapy in the management of central cranial diabetes insipidus and after head trauma or surgery in the pituitary region Desmopressin Acetate Nasal Spray 10 (more...)

Where Can You Learn About Drug Recalls? At Ferrer, Poirot & Wansbrough, it’s our job to help people harmed by defective and recalled medications get the compensation they deserve. But our years of experience has taught us that many patients aren’t aware that their medications have been recalled until it’s too late. Unfortunately, it’s not uncommon for drug recalls to be underreported, (more...)

What is NDMA and Why is It in Many Recalled Drugs? On April 15, 2020, the U.S. Food and Drug Administration posted a notice on its website that a Nizatidine Oral Solution 15 mg/mL product was recalled due to containing high levels of nitrosodimenthylamine (NDMA). The product is manufactured by Amneal Pharmaceuticals, LLC, and distributed by its subsidiary Gemini Laboratories, LLC. NDMA is classified as a (more...)

Are You at a Higher Risk of COVID-19 Complications? COVID-19, also known as novel coronavirus, has dominated the news over the past several weeks. Most states have mandatory stay-at-home orders, with non-essential businesses being closed and travel limited or restricted. And while staying home can reduce your chances of being infected, that’s not always a possibility for all individuals and families. In addition, all (more...)